Literature DB >> 32290313

Reply to Comments: Using the Cardio-Ankle Vascular Index (CAVI) or the Mathematical Correction Form (CAVI0) in Clinical Practice.

Bart Spronck1,2, Alexander Jurko3, Michal Mestanik4,5, Alberto P Avolio6, Ingrid Tonhajzerova4,5.   

Abstract

We read with great interest Alizargar et al [...].

Entities:  

Mesh:

Year:  2020        PMID: 32290313      PMCID: PMC7178141          DOI: 10.3390/ijms21072647

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


We read with great interest Alizargar et al.’s comment on our recent review on biomarkers in cervical cancer and human papillomavirus infection [1,2]. In their comment, they raise important questions and concerns about using cardio-ankle vascular index (CAVI) and CAVI0 [3,4]. We would like to take this opportunity to elaborate our considerations in deriving CAVI0, and to point out some potential misconceptions on the corrections that CAVI and CAVI0 do and do not perform. Due to the nonlinear elastic behavior of the artery wall, a higher blood pressure results in a higher pulse wave velocity (PWV) at the time of measurement [5,6,7]. It is this inherent blood pressure dependency that both CAVI and CAVI0 aim to correct for. Notably, different individuals with different blood pressures may show a different PWV due to (1) pressure dependency of PWV, and/or (2) intrinsic (“actual”) differences in arterial stiffness [8]. CAVI and CAVI0 only correct—and should only correct—for the first effect. Differences in intrinsic arterial stiffness between individuals, e.g., due to hypertensive remodeling, age, obesity, etc., should be reflected in CAVI/CAVI0, thus allowing for the use of CAVI and CAVI0 to study the effect of such phenomena on arterial stiffness. After all, if a stiffness index did not vary with any of those phenomena, there would be no use in measuring it, and it would not predict any outcome. In a recent study, Shirai et al. compared CAVI and CAVI0 in a large population of normotensive and hypertensive individuals [9]. While the use of large populations should be greatly applauded, all analyses presented in their study are cross-sectional, that is, in each individual, CAVI/CAVI0 was measured only once. Therefore, relations with blood pressure observed in such a study will reflect both intrinsic (nonlinear elasticity; within-subject) blood pressure dependency and between-subject differences in intrinsic arterial stiffness. As elaborated in the previous paragraph, CAVI and CAVI0 are only meant to correct the former and not the latter effect. It is clear, therefore, that cross-sectional studies, while very useful to study population patterns and to derive reference values, cannot be used to assess the performance of CAVI and CAVI0 in correcting for the intrinsic blood pressure dependency of PWV [8]. Such studies simply contain both effects mixed together, without a way to disentangle them. Alizargar et al. point out that Shirai et al. observed a negative, “inexplicable” correlation between CAVI0 and diastolic blood pressure (DBP) in healthy individuals, which Shirai et al. then used as a reason to label CAVI0 as “inappropriate” [1,9]. Again, this correlation is cross-sectional, and indicates (statistically) that subjects with a higher CAVI0 on average have a lower DBP. This could be explained as follows. Subjects with (intrinsically) stiffer arteries typically have a larger pulse pressure than subjects with less stiff arteries. As these subjects were classified as healthy (i.e., not hypertensive), their systolic blood pressure was probably approximately normotensive. The DBP of the individuals with stiffer arteries, however, could well have been lower than that of those with less stiff arteries, which potentially explains the negative cross-sectional correlation between CAVI0 and DBP as observed by Shirai et al. Alizargar et al. also mention that in our initial study, we did not take into account physiological properties of individuals, such as body mass index (BMI) [1,4]. Again, BMI is a cross-sectional property that varies between individuals. CAVI/CAVI0 were never aimed to be BMI-independent. In our initial study, we simulated subjects with differing values of intrinsic stiffness. Such differences could be interpreted as being due to BMI, age, calcification, arteriosclerosis, etc. However, the aim of our study was not to investigate the effects of these particular phenomena; it was merely to illustrate how, in a typical study cohort with (patho)physiological differences in intrinsic stiffness among subjects, blood pressure fluctuations could (theoretically) influence CAVI and CAVI0 measurements. Calculation of CAVI involves the use of two scale parameters (a and b) that were recently disclosed to the public [10]. This disclosure allows for an accurate, exact (instead of estimated [11]) conversion from CAVI to CAVI0 [12]. Different combinations of a/b parameters are used for different CAVI ranges [10], the effects of which were criticized by Ato et al. [13]. Notably, CAVI0 does not use such scale parameters. Considering these criticisms, as well as the CAVI-CAVI0 discussion, Alizargar et al. suggest that normal PWV and stiffness index β may be more reliable indices than the (less established) CAVI and CAVI0 [1]. We agree that PWV indeed is more established, and has the advantage that it is “simpler”, or “closer to the measurement”, but with the trade-off of being inherently blood pressure dependent. Stiffness index β (termed heart-ankle β or haβ for the heart-to-ankle trajectory), CAVI, and CAVI0 are all much less blood pressure dependent than PWV [4,10,14], and hence, have the potential of being more “intrinsic” metrics of arterial stiffness. Therefore, potentially, the values of such indices may be more directly interpretable as “arterial stiffness” than PWV values. To conclude, we would like to re-emphasize that we consider the development and practical application of CAVI, as extensively described by Dr. Shirai and colleagues [3,10], to be innovative and based on sound and robust physiological principles. In our paper and discussion with Dr. Shirai, we aimed to provide additional clarification and suggested improvements by using CAVI0 [4,15,16,17,18]. We consider it also important to point out that the difference between statistical corrections based on cross-sectional and longitudinal/repeated measures studies can confound the interpretation of the difference between pressure dependency and intrinsic properties of arterial stiffness.
  16 in total

1.  Contradictory effects of β1- and α1- aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)--CAVI independent of blood pressure.

Authors:  Kohji Shirai; Mingling Song; Jun Suzuki; Takumi Kurosu; Tomokazu Oyama; Daiji Nagayama; Yoh Miyashita; Shigeo Yamamura; Mao Takahashi
Journal:  J Atheroscler Thromb       Date:  2010-11-06       Impact factor: 4.928

2.  Pressure-dependence of arterial stiffness: potential clinical implications.

Authors:  Bart Spronck; Maarten H G Heusinkveld; Floris H Vanmolkot; Jos Op 't Roodt; Evelien Hermeling; Tammo Delhaas; Abraham A Kroon; Koen D Reesink
Journal:  J Hypertens       Date:  2015-02       Impact factor: 4.844

3.  Reply: physics cannot be disputed.

Authors:  Bart Spronck; Alberto P Avolio; Isabella Tan; Mark Butlin; Koen D Reesink; Tammo Delhaas
Journal:  J Hypertens       Date:  2017-07       Impact factor: 4.844

4.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

Authors:  Kohji Shirai; Junji Utino; Kuniaki Otsuka; Masanobu Takata
Journal:  J Atheroscler Thromb       Date:  2006-04       Impact factor: 4.928

5.  Reply: Medical science is based on facts and evidence.

Authors:  Bart Spronck; Alberto P Avolio; Isabella Tan; Mark Butlin; Koen D Reesink; Tammo Delhaas
Journal:  J Hypertens       Date:  2018-04       Impact factor: 4.844

6.  Medical science is based on evidence (answer to Spronck et al.'s refutation: physics cannot be disputed).

Authors:  Kohji Shirai; Masanobu Takata; Akira Takahara; Kazuhiro Shimizu
Journal:  J Hypertens       Date:  2018-04       Impact factor: 4.844

Review 7.  Options for Dealing with Pressure Dependence of Pulse Wave Velocity as a Measure of Arterial Stiffness: An Update of Cardio-Ankle Vascular Index (CAVI) and CAVI0.

Authors:  Bart Spronck; Tammo Delhaas; Mark Butlin; Koen D Reesink; Alberto P Avolio
Journal:  Pulse (Basel)       Date:  2017-09-07

8.  Evaluation of the calculation formulas of the cardio-ankle vascular index used in the Japanese apparatus.

Authors:  Dai Ato
Journal:  Vasc Health Risk Manag       Date:  2019-09-13

Review 9.  Novel Biomarkers of Early Atherosclerotic Changes for Personalised Prevention of Cardiovascular Disease in Cervical Cancer and Human Papillomavirus Infection.

Authors:  Ingrid Tonhajzerova; Lucia B Olexova; Alexander Jurko; Bart Spronck; Tomas Jurko; Nikola Sekaninova; Zuzana Visnovcova; Andrea Mestanikova; Erik Kudela; Michal Mestanik
Journal:  Int J Mol Sci       Date:  2019-07-30       Impact factor: 5.923

10.  Using the Cardio-Ankle Vascular Index (CAVI) or the Mathematical Correction Form (CAVI0) in Clinical Practice.

Authors:  Javad Alizargar; Nan-Chen Hsieh; Shu-Fang Vivienne Wu; Shih-Yen Weng
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

View more
  1 in total

1.  Predictive Ability of Pressure-Corrected Arterial Stiffness Indices: Comparison of Pulse Wave Velocity, Cardio-Ankle Vascular Index (CAVI), and CAVI0.

Authors:  Bart Spronck; Mary Jo Obeid; Mahati Paravathaneni; Naga Vaishnavi Gadela; Gurpreet Singh; Caroline A Magro; Varsha Kulkarni; Soumya Kondaveety; Keerthi Chandrika Gade; Rushik Bhuva; Colin M Kulick-Soper; Nicolas Sanchez; Scott Akers; Julio A Chirinos
Journal:  Am J Hypertens       Date:  2022-03-08       Impact factor: 2.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.